Huntington Hospital named an Anticoagulation Center of Excellence

Huntington Hospital is pleased to announce that we have passed the Anticoagulation (AC) Forum’s assessment test and will continue as an “Anticoagulation Center of Excellence.” This designation, initially obtained in 2016, illustrates Huntington Hospital’s strong commitment to providing the highest level of care to patients taking antithrombotic medications.

“We are very proud to have passed the Anticoagulation Centers of Excellence assessment,” said Gabriella Sherman, MD, MBA, Vice President, Quality & Clinical Operations, Huntington Hospital. “We are dedicated to actively participating in all aspects of our patients’ care to improve health outcomes and this recognition reflects our commitment to community well-being.”

The Anticoagulation Centers of Excellence program helps healthcare professionals provide the highest level of care and achieve the best possible outcomes for patients on antithrombotic medications. The program offers a roadmap to consistent, sustainable excellence in five key areas of patient care. Because it successfully met the rigorous standards in each patient care pillar, Huntington Hospital may be considered an Anticoagulation Center of Excellence for two years.

“The assessment and educational resources on the AC Forum site helped us streamline our operational performance, improve transition of care and knowledge of drug therapy, and enhance patient education while learning more about disease state management,” said Tommy Mai, PharmD, Director of Pharmacy Services, Huntington Hospital. “Congratulations to our team for their hard work and dedication to achieve this important designation.”

An antithrombotic medication is a drug that reduces the formation of blood clots (thrombi). Antithrombotics can be used therapeutically for prevention or treatment of a dangerous blood clot (acute thrombus).

Huntington Hospital’s Medication Therapy Management (MTM) Clinic is operated by pharmacists and provides a variety of outpatient services to patients, including anticoagulation management. The MTM Clinic monitors and educates patients about blood-thinning medications such as warfarin (Coumadin®), enoxaparin (Lovenox®), dabigatran (Pradaxa®), rivaroxaban (Xarelto®), apixaban (Eliquis®) and edoxaban (Savaysa®) through in-person visits in the clinic.

For more information, click here.

The Anticoagulation Forum is a multidisciplinary non-profit organization that works to improve the quality of care for patients taking antithrombotic medications. The AC Forum promotes the clinical application of evidence-based practices, and provides education and networking opportunities for healthcare professionals. To learn more about the program visit www.excellence.acforum.org